Markets:

Overview

News

Currencies

International

Treasuries

Inhibrx Biosciences, Inc. - Common Stock (NQ:INBX)

85.09 -1.40 (-1.62%)

Streaming Delayed Price Updated: 12:44 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Inhibrx Biosciences, Inc. - Common Stock

< Previous 1 2 3 Next >

Earnings Scheduled For November 14, 2025 ↗

November 14, 2025

Via Benzinga

Unusual volume stocks in Thursday's session ↗

October 30, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

The trading volume of these stocks is deviating from the norm in today's session. ↗

October 28, 2025

Unusual volume stocks are being observed in Tuesday's session.

Via Chartmill

Why Is INBX Stock Rising Today? ↗

October 24, 2025

Via Stocktwits

INBX Stock Earnings: Inhibrx Beats EPS for Q1 2024 ↗

August 22, 2024

INBX stock results show that Inhibrx beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

US Stocks Jump To Records Amid Weak Inflation: Investor Fear Eases, Greed Index Remains In 'Fear' Zone ↗

October 27, 2025

Stocks hit all-time highs as inflation eased, boosting confidence for Fed rate cut. Fear & Greed Index shows fear, but higher stock prices.

Via Benzinga

Topics Economy

Inhibrx Biosciences Soars Over 90% on Breakthrough Rare Bone Cancer Trial Results

October 24, 2025

San Diego, CA – October 24, 2025 – Inhibrx Biosciences, Inc. (NASDAQ: INBX) witnessed an extraordinary surge in its stock price today, rocketing by over 94% in early trading, following the announcement...

Via MarketMinute

Here are the top movers in Friday's session. ↗

October 24, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Stocks Soar To Records After Weak Inflation, Ford Jumps 10%: What's Moving Markets Friday? ↗

October 24, 2025

Wall Street surged to fresh all-time highs Friday as a softer-than-expected inflation reading strengthened market conviction that the Federal Reserve will cut interest rates by 25 basis points at its...

Via Benzinga

Topics Economy

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 24, 2025

Via Benzinga

What's going on in today's session ↗

October 24, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

Dow Jumps Over 500 Points; US Consumer Sentiment Declines In October ↗

October 24, 2025

Via Benzinga

Topics Stocks

Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment

October 24, 2025

San Diego, CA – October 24, 2025 – Inhibrx (NASDAQ: INBX) shares have surged dramatically, skyrocketing over 70% in pre-market and after-hours trading, following the announcement of overwhelmingly...

Via MarketMinute

Ford, Inhibrx Biosciences, Comfort Systems, Western Union And Other Big Stocks Moving Higher On Friday ↗

October 24, 2025

Via Benzinga

Which stocks are gapping on Friday? ↗

October 24, 2025

Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Get insights into the top gainers and losers of Friday's pre-market session. ↗

October 24, 2025

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 24, 2025

Via Benzinga

Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 24, 2025

Via Benzinga

Why Are Inhibrx Biosciences Shares Soaring 76% After Hours? ↗

October 24, 2025

Inhibrx Biosciences shares surged nearly 76% in after-hours trading Thursday after the company reported positive Phase 2 trial results for its cancer drug Ozekibart.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 23, 2025

Via Benzinga

Get insights into the top gainers and losers of Thursday's after-hours session. ↗

October 23, 2025

After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 22, 2025

Via Benzinga

Inhibrx Biosciences Beats Earnings ↗

August 13, 2025

Via The Motley Fool

Topics Intellectual Property

Around $2M Bet On Franklin Resources? Check Out These 4 Stocks Executives Are Buying ↗

September 03, 2024

Via Benzinga

Over $7M Bet On This Health Care Stock? Check Out These 3 Stocks Executives Are Buying ↗

August 27, 2024

Via Benzinga

INBX Stock Earnings: Inhibrx Biosciences Beats EPS for Q2 2024 ↗

August 14, 2024

INBX stock results show that Inhibrx Biosciences beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Top 4 Health Care Stocks That Are Preparing To Pump This Month ↗

June 05, 2024

Via Benzinga

The NVDA Earnings Effect And What It Means For The Current Market Momentum ↗

February 28, 2024

Discover the confluence zone that will make or break the S&P 500 and the preliminary supply (early distribution) you need to be aware of.

Via Talk Markets

Topics Stocks

Is The Stock Market Ready To Plunge? The Warning Signs Are Here... ↗

February 21, 2024

Find out how to spot the exhaustion of demand and the bearish analogue you could refer to to anticipate the down move.

Via Talk Markets

Sanofi Barrels Into Liver Disease Space With $1.7 Billion Takeover Of Inhibrx ↗

January 23, 2024

The company is buying Inhibrx, which is working on a treatment for alpha-1 antitrypsin deficiency.

Via Investor's Business Daily

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Inhibrx Biosciences, Inc. - Common Stock (NQ:INBX)

Headline News about Inhibrx Biosciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today